Literature DB >> 14610231

L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia.

S M Rawls1, R J Tallarida, A M Gray, Ellen B Geller, Martin W Adler.   

Abstract

Cannabinoids evoke profound hypothermia in rats by activating central CB(1) receptors. Nitric oxide (NO), a prominent second messenger in central and peripheral neurons, also plays a crucial role in thermoregulation, with previous studies suggesting pyretic and antipyretic functions. Dense nitric-oxide synthase (NOS) staining and CB(1) receptor immunoreactivity have been detected in regions of the hypothalamus that regulate body temperature, suggesting that intimate NO-cannabinoid associations may exist in the central nervous system. The present study investigated the effect of N(omega)-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor, on the hypothermic response to WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a selective cannabinoid agonist, in rats. WIN 55212-2 (1-5 mg/kg, i.m.) produced dose-dependent hypothermia that peaked 45 to 90 min post-injection. L-NAME (10-100 mg/kg, i.m.) by itself did not significantly alter body temperature. However, a nonhypothermic dose of L-NAME (50 mg/kg) potentiated the hypothermia caused by WIN 55212-2 (0.5-5 mg/kg). The augmentation was strongly synergistic, indicated by a 2.5-fold increase in the relative potency of WIN 55212-2. The inactive enantiomer of WIN 55212-2, WIN 55212-3 [S-(-)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-napthanlenyl) methanone mesylate] (5 mg/kg, i.m.), did not produce hypothermia in the absence or presence of L-NAME (50 mg/kg), confirming that cannabinoid receptors mediated the synergy. The present data are the first evidence that drug combinations of NOS blockers and cannabinoid agonists produce synergistic hypothermia. Thus, NO and cannabinoid systems may interact to induce superadditive hypothermia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610231     DOI: 10.1124/jpet.103.054668

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids.

Authors:  R Antonio Herrera; Joseph H Oved; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

2.  Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States.

Authors:  Stefania I Papatheodorou; Hannah Buettner; Mary B Rice; Murray A Mittleman
Journal:  Chest       Date:  2016-01-16       Impact factor: 9.410

3.  Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.

Authors:  Peng Huang; Julia Tunis; Christopher Parry; Ronald Tallarida; Lee-Yuan Liu-Chen
Journal:  Eur J Pharmacol       Date:  2016-04-01       Impact factor: 4.432

Review 4.  Effects of opioids, cannabinoids, and vanilloids on body temperature.

Authors:  Scott M Rawls; Khalid Benamar
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

Review 5.  Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters.

Authors:  M V Fogaça; S F Lisboa; D C Aguiar; F A Moreira; F V Gomes; P C Casarotto; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-03-08       Impact factor: 2.590

6.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

7.  Nitric oxide in the nucleus raphe magnus modulates cutaneous blood flow in rats during hypothermia.

Authors:  Masoumeh Kourosh Arami; Javad Mirnajafi Zade; Alireza Komaki; Mahmood Amiri; Sara Mehrpooya; Ali Jahanshahi; Behnam Jamei
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

8.  ULTRASOUND INDUCED MICROBUBBLE CAVITATION FOR THE TREATMENT OF CATHETERIZATION INDUCED VASOSPASM.

Authors:  Shelby Kutty; Na Liu; Jia Zhou; Yunbin Xiao; Juefei Wu; David Danford; John Lof; Feng Xie; Thomas R Porter
Journal:  JACC Basic Transl Sci       Date:  2017-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.